Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Pediatric Infectious Disease|September 1, 1985
Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndromeJ E Kaplan, J M Oleske, J P Getchell, et al.
Annals of Internal Medicine|August 1, 1983
National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 2. Laboratory resultsM F Rogers, D M Morens, J A Stewart, et al.
The Western Journal of Medicine|February 1, 1986
Hemolytic-uremic syndrome--an outbreak in Sacramento, CaliforniaM F Rogers, L D Budnick, I Kirson, et al.
The Journal of Infectious Diseases|May 1, 1997
Evaluation of pharmacokinetics, safety, tolerance, and activity of combination of zalcitabine and zidovudine in stable, zidovudine-treated pediatric patients with human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 190 TeamS S Bakshi, P Britto, E Capparelli, et al.
The New England Journal of Medicine|June 12, 1997
Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 TeamJ A Englund, C J Baker, C Raskino, et al.
JAMA|March 3, 1989
Pregnancy-associated deaths due to AIDS in the United StatesL M Koonin, T V Ellerbrock, H K Atrash, et al.
American Journal of Epidemiology|August 1, 1986
Kawasaki syndrome: a controlled study of an outbreak in WisconsinB S Klein, M F Rogers, L A Patrican, et al.
JAMA|March 3, 1989
Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug usersP A Selwyn, E E Schoenbaum, K Davenny, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 4, 1999
Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudineI C Hanson, T A Antonelli, R S Sperling, et al.
The New England Journal of Medicine|August 5, 1999
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 TeamL M Mofenson, J S Lambert, E R Stiehm, et al.
Pageof 10